Drugs for anxiety: from chloral hydrate to novel therapeutics.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 42204914.
- Also identified by DOI 10.1192/bjp.2026.10598.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Anxiety disorders are common and disabling. Current drugs have limited efficacy, notable side-effects and little innovation. This editorial briefly reviews past, current and emerging anxiolytic treatments, including psychedelic-assisted therapies, and highlights key themes. There remains a major need for improved medications to reduce disability and improve quality of life.
Medical subject headings
- Anti-Anxiety Agents
- Anxiety Disorders
- Chloral Hydrate